Is REPLIGEN CORP (RGEN) Halal?
Shariah Screening — 5 Standards
Based on financial data from December 2025
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | 10.2% / 30% | 11.2% / 30% | 2.0% / 30% | N/A | ✓ HALAL |
| DJIM | 10.2% / 33% | 11.2% / 33% | 2.0% / 33% | N/A | ✓ HALAL |
| MSCI | 24.3% / 33% | 26.8% / 33% | 4.7% / 33% | N/A | ✓ HALAL |
| S&P | 10.2% / 33% | 11.2% / 33% | 2.0% / 33% | N/A | ✓ HALAL |
| FTSE | 24.3% / 33% | 26.8% / 33% | 4.7% / 50% | N/A | ✓ HALAL |
Financial Highlights
Profitability
| Gross Margin | 52.7% | |
| Operating Margin | 8.3% | |
| Net Margin | 6.6% | |
| Return on Equity (ROE) | 2.4% | |
| Return on Assets (ROA) | 1.0% |
Cash Flow & Balance Sheet
| Operating Cash Flow | $117M |
| Free Cash Flow | $92M |
| Total Debt | $690M |
| Debt-to-Equity | 32.8 |
| Current Ratio | 8.4 |
| Total Assets | $2.9B |
Price & Trading
| Last Close | $114.42 |
| 50-Day MA | $135.72 |
| 200-Day MA | $138.52 |
| Avg Volume | 780K |
| Beta | 1.2 |
|
52-Week Range
$102.97
| |
About REPLIGEN CORP (RGEN)
Repligen Corporation, a life sciences company, develops and commercializes bioprocessing technologies and systems in North America, Europe, the Asia Pacific, and internationally. The company's products include hollow fiber consumables, KRM chromatography system, resins for new modalities, PATsmart MAVERICK and PATsmart MAVEN for real-time monitoring and control of critical bioprocess parameters, PATsmart REBEL, an at-line cell culture media analyzer; and PATsmart ZipChip, a high-resolution sample separations device, PATsmart SoloVPE slope spectroscopy system, and SoloVPE PLUS System. It offers Protien A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products. The company also provides chromatography products, including OPUS pre-packed chromatography columns, which are used in the purification and quality control of biological drugs, as well as ELISA test kits. In addition, it offers filtration products, such as XCell ATF Cell Retention Systems that are filtration devices used in upstream perfusion and cell culture processing; TangenX flat sheet cassettes, which are used in downstream biologic drug concentration, buffer exchange, and formulation processes; KrosFlo tangential flow filtration and tangential flow depth filtration systems; and ProConnex TFDF flow paths. Further, it provides process analytics products, such as slope spectroscopy systems. The company offers its products under the OPUS, XCell, XCell ATF, TFDF, KrosFlo, SIUS, ProConnex, Spectra/Por, NGL-Impact, SoloVPE, FlowVPE, RPM, XO, Metenova MixOne, and AVIPure and FlowVPX brands. The company sells its products to life sciences, biopharmaceutical, and diagnostics companies; laboratory researchers; and contract manufacturing organizations. Repligen Corporation has a collaboration agreement with Navigo Proteins GmbH to develop multiple affinity ligands. The company was incorporated in 1981 and is headquartered in Waltham, Massachusetts.
Related Halal Stocks in Healthcare
Frequently Asked Questions
Is REPLIGEN CORP (RGEN) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), REPLIGEN CORP is Halal. The company passes all financial ratio thresholds for debt, cash, receivables, and impermissible income. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is REPLIGEN CORP's debt ratio?
REPLIGEN CORP's debt ratio is 10.2% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 24.3%.
What are REPLIGEN CORP's key financial metrics?
REPLIGEN CORP has a market capitalization of $6.2B, trailing P/E ratio of 128.0, and revenue of $738M. The company maintains a gross margin of 52.7% and a net margin of 6.6%. Return on equity stands at 2.4%.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.